Ownership and insider activity for Sotera Health Company (SHC): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses.
Price
| Price | $18.55 |
| Market Cap | $5.3B |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $96.3M | $62.9M | $102.4M | $106.9M | $395.2M | $296.4M | $277.2M | $346.5M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $141.6M | $111.6M | $131.0M | $134.0M | $155.7M | $175.5M | $165.8M | $176.3M |
| Inventory | $37.6M | $37.4M | $34.1M | $54.3M | $37.1M | $48.3M | $49.2M | $59.4M |
| Total Current Assets | $312.9M | $252.4M | $315.0M | $346.0M | $645.0M | $557.2M | $526.0M | $613.4M |
| Property, Plant & Equipment | $586.4M | $582.0M | $655.8M | $690.7M | $801.0M | $971.0M | $1.06B | $1.16B |
| Goodwill | $1.02B | $1.04B | $1.12B | $1.12B | $1.10B | $1.11B | $1.08B | $1.10B |
| Intangible Assets | $766.1M | $696.0M | $643.4M | $598.8M | $491.3M | $416.3M | $317.7M | $288.2M |
| Total Assets | $2.71B | $2.58B | $2.76B | $2.79B | $3.12B | $3.13B | $3.07B | $3.26B |
| Accounts Payable | $46.4M | $42.0M | $52.4M | $72.9M | $74.1M | $71.0M | $55.1M | $78.0M |
| Short-term Debt | $15.3M | $16.3M | 0 | 0 | $197.1M | $4.8M | $14.8M | $23.2M |
| Total Current Liabilities | $143.4M | $124.0M | $140.6M | $161.2M | $791.6M | $230.7M | $191.0M | $249.6M |
| Long-term Debt | $2.19B | $2.80B | $1.82B | $1.74B | $1.75B | $2.22B | $2.21B | $2.13B |
| Total Liabilities | $2.66B | $3.22B | $2.31B | $2.20B | $2.77B | $2.69B | $2.67B | $2.66B |
| Retained Earnings | -$10.4M | -$550.5M | -$589.1M | -$472.2M | -$705.8M | -$654.4M | -$610.0M | -$532.1M |
| Total Equity | $44.4M | -$642.6M | $452.3M | $586.1M | $350.2M | $443.7M | $404.9M | $606.0M |
| Total Debt | $2.24B | $2.85B | $1.91B | $1.83B | $2.03B | $2.33B | $2.35B | $2.27B |
| Net Debt | $2.14B | $2.79B | $1.81B | $1.72B | $1.64B | $2.03B | $2.07B | $1.93B |
| Working Capital | $169.5M | $128.4M | $174.4M | $184.8M | -$146.6M | $326.6M | $335.0M | $363.8M |
Financial Health
| Debt / Equity | 3.41 |
| Current Ratio | 2.80 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 1.79 |
Profitability
| Return on Equity | 26.75% |
| Return on Invested Capital | 8.80% |
| Return on Assets | 4.94% |
| Gross Margin | 54.72% |
| Operating Margin | 36.24% |
| Net Margin | 13.44% |
Related companies: ALKS · BLCO · GKOS · MMSI · OPCH · OSCR
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of SHC: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks